Author

J. M. Rosen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

C. Hamor· 2 shared D. K. Cullen· 2 shared F. A. Laimo· 2 shared H. M. Kaplan· 2 shared J. C. Burrell· 2 shared Y. Gao· 2 shared Z. Ali· 2 shared A. Chaudhury· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Hamor

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics

Y. Gao, E. B. Kabotyanski, E. Villegas, J. H. Shepherd, D. Acosta, C. Hamor, T. Sun, C. Montemayor-Garcia, X. He, L. E. Dobrolecki, T. F. Westbrook, M. T. Lewis, S. G. Hilsenbeck, X. H.- F. Zhang, C. M. Perou, J. M. Rosen

This study shows PLK2 loss predicts better response to PLK1 inhibitors in triple-negative breast cancer and suggests PLK2 as a biomarker for treatment response.

bioRxiv · Jun 16, 2021Cancer Biology

Chemotherapy coupled to macrophage inhibition leads to enhanced T and B cell infiltration and durable triple negative breast cancer regression

S. Singh, N. Lee, D. Pedroza, I. Bado, C. Hamor, L. Zhang, S. Aguirre, J. Hu, Y. Shen, Y. Xu, Y. Gao, N. Zhan, S.-H. Chen, Y.-W. Wan, Z. Liu, , J. M. Rosen

bioRxiv · Feb 22, 2021 · PreprintCancer Biology

Tissue Engineered Axon-Based Living Scaffolds Promote Survival of Spinal Cord Motor Neurons Following Peripheral Nerve Repair

J. C. Maggiore, J. C. Burrell, K. D. Browne, K. C. Katiyar, F. A. Laimo, Z. Ali, H. M. Kaplan, J. M. Rosen, D. K. Cullen

This study compares living and non-living scaffolds for nerve repair, finding that tissue-engineered grafts (TENGs) preserve motor neuron health and function as effectively as autografts.

bioRxiv · Sep 22, 2020Bioengineering

Tyrosine-Derived Polycarbonate Nerve Guidance Tubes Elicit Pro-Regenerative Extracellular Matrix Deposition When Used to Bridge Segmental Nerve Defects in Swine

J. C. Burrell, D. Bhatnagar, D. P. Brown, N. S. Murthy, J. Dutton, F. A. Laimo, Z. Ali, J. M. Rosen, H. M. Kaplan, J. Kohn, D. K. Cullen

This study evaluates tyrosine-derived polycarbonate nerve guidance tubes in swine, showing they promote pro-regenerative extracellular matrix deposition and Schwann cell infiltration compared to collagen-based tubes.

bioRxiv · Jan 11, 2020Bioengineering

CELF1 is an EIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs

A. Chaudhury, R. Pal, N. Kongchan, N. Zhao, Y. Zhu, E. Olokpa, S. Cheema, S. del Rincon, L. C. Reineke, S. Mao, R. E. Llyod, M. Sardiello, J. M. Rosen, J. R. Neilson

The paper shows CELF1 binds eIF4E and PABP to promote translation of EMT effector mRNAs, and disrupting this interaction inhibits EMT and metastasis.

bioRxiv · May 16, 2019 · PreprintCancer Biology